TRIUMPH-Outcomes is not required for initial obesity approval but will be critical for long-term payer and labeling decisions
For patients with hypothyroidism who are stable on levothyroxine replacement therapy, GLP-1 receptor agonist weight loss injections are generally not contraindicated
The fix isnt avoiding stopping, its planning the transition: a slow taper, continued strength training, and a defined nutrition plan
Frequently asked questions What is the lowest effective starting dose of retatrutide
10.1172/JCI78371 J Clin Invest
What to Expect in Month 2 Peak nausea: Weeks 6-8 worst for most patients, especially mornings Food aversions: Foods you loved suddenly repulsive (especially meat, coffee) Early satiety: Feel full after 3-4 bites, physical discomfort if you push it Fatigue increases: Combination of medication adjustment and reduced calorie intake Bowel unpredictability: Constipation one day, diarrhea the next Mental fog: Some patients report difficulty concentrating Research from the New England Journal of Medicine on incretin therapies shows this peak-and-resolution pattern is universal across GLP-1 and GIP agonists
